A PYMNTS Company

The Interplay of Patenting Strategies and Competition Law in the Pharmaceutical Sector Inquiry

BY | February 24, 2009

This article is part of a Chronicle. See more from this Chronicle Kristina Nordlander, Stephen Spinks, Feb 24, 2009 In the presentation of its Preliminary Report on the pharmaceutical sector…

This article is part of a Chronicle. See more from this Chronicle

Kristina Nordlander, Stephen Spinks, Feb 24, 2009

In the presentation of its Preliminary Report on the pharmaceutical sector inquiry, the European Commission attempted to perform a delicate balancing of competition and International Property (“IP”) law. While the Commission went out of its way repeatedly to state that the value of IP rights in general, and patents in particular, are not in dispute in the sector inquiry

...
THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 44.192.15.251

Please verify email or join us to access premium content!